0
Abstract: Slide Presentations |

EUS-GUIDED PLACEMENT OF FIDUCIALS FOR CYBERKNIFE THERAPY: A NEW AND SAFE METHOD TO PLACE FIDUCIALS IN THE MEDIASTINAL AND ABDOMINAL TUMORS FREE TO VIEW

Nadim G. Haddad, MD*
Author and Funding Information

Georgetown University Hospital, Washington, DC



Chest. 2006;130(4_MeetingAbstracts):146S-d-147S. doi:10.1378/chest.130.4_MeetingAbstracts.146S-d
Text Size: A A A
Published online

Abstract

PURPOSE: Objective: The goal of this study was to evaluate the safety and feasibility of placing fiducials in mediastinal and intra-abdominal tumors under EUS guidance. A secondary goal was to determine whether or not fiducials placed under EUS guidance were suitable as markers for CyberKnife.

METHODS: Design: Thirteen patients scheduled to for CyberKnife therapy were evaluated for EUS-guided placement. A linear echoendoscope was used to localize the tumor, insert a 19-gauge FNA needle inseted in tumor and fiducials(3-5 mm) placed. However, when for technical reasons the 5mm fiducials could not be placed, 3mm fiducials were inserted instead. The position of the fiducials was verified by EUS and by fluoroscopy.

RESULTS: Results: EUS-guided fiducial placement was successful in a total of 11/13 patients (84.6%). The locations of the tumors were as follow: retrocrural area at the dome of the diaphragm, porta hepatis, gastroesophageal junction, mediastinum, thoracic paraspinal area and pancreas. Fiducials placement was not attempted in 2 patients because the tumors were not (safely) accessible to the EUS needle. A total of 3 to 6 fiducials were placed in each patient. Fiducials length was 5mm in 9 patients and 3mm in 2 patients. One patient developed an infectious complication that resolved with antibiotics. Of the 11 patients who had fiducials placed, three were not treated because of deterioration of their clinical status. For the other 8 patients, the fiducials were adequate for detection by the CyberKnife system, whether they were of 3mm or 5mm length. No fiducial migrated significantly from its initial position throughout the treatment period.

CONCLUSION: Conclusion: EUS-guided fiducial placement in lesions of the mediastinum and abdomen is a feasible and safe technique that can be used to mark a tumor site and guide CyberKnife radiation therapy.

CLINICAL IMPLICATIONS: A new and less invasive technique that would help to target tumors in areas that were diffucult to reach in conventional ways.

DISCLOSURE: Nadim Haddad, None.

Wednesday, October 25, 2006

10:30 AM - 12:00 PM


Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543